LIXIL Corporation
LIXIL Corporation (JSGCF) Financial Performance & Income Statement Overview
Analyze LIXIL Corporation (JSGCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
LIXIL Corporation (JSGCF) Income Statement & Financial Overview
View the income breakdown for LIXIL Corporation JSGCF across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $364.24B | $400.68B | $369.96B | $369.81B |
| Cost of Revenue | $243.17B | $264.83B | $246.13B | $252.46B |
| Gross Profit | $121.07B | $135.85B | $123.84B | $117.35B |
| Gross Profit Ratio | $0.33 | $0.34 | $0.33 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $120.80B | $115.30B | $113.96B | $116.72B |
| Operating Expenses | $120.80B | $115.30B | $113.96B | $117.84B |
| Total Costs & Expenses | $363.97B | $380.12B | $360.09B | $370.30B |
| Interest Income | $1.09B | $790.00M | $989.00M | $1.13B |
| Interest Expense | $3.69B | $2.32B | $3.96B | $3.88B |
| Depreciation & Amortization | $0.00 | $20.82B | $20.72B | $21.11B |
| EBITDA | $2.37B | $39.35B | $31.08B | $20.62B |
| EBITDA Ratio | $0.006 | $0.10 | $0.08 | $0.06 |
| Operating Income | $267.00M | $20.56B | $9.87B | -$482.00M |
| Operating Income Ratio | $0.001 | $0.05 | $0.03 | -$0.001 |
| Other Income/Expenses (Net) | -$1.59B | -$3.37B | -$2.48B | -$2.79B |
| Income Before Tax | -$1.33B | $17.19B | $7.39B | -$3.28B |
| Income Before Tax Ratio | -$0.004 | $0.04 | $0.02 | -$0.009 |
| Income Tax Expense | $1.20B | $8.79B | $5.50B | $2.39B |
| Net Income | -$2.28B | $8.21B | $1.93B | -$5.86B |
| Net Income Ratio | -$0.006 | $0.02 | $0.005 | -$0.02 |
| EPS | -$7.97 | $27.97 | $6.71 | -$19.88 |
| Diluted EPS | -$7.97 | $27.71 | $6.71 | -$20.39 |
| Weighted Avg Shares Outstanding | $286.14M | $296.39M | $287.16M | $294.61M |
| Weighted Avg Shares Outstanding (Diluted) | $287.27M | $287.28M | $287.16M | $287.22M |
Over the last four quarters, LIXIL Corporation's revenue moved from $369.81B in Q1 2024 to $364.24B in Q4 2024. Operating income in Q4 2024 was $267.00M, with a strong operating margin of 0%. Despite fluctuations in R&D and SG&A expenses, EBITDA for LIXIL Corporation remained robust at $2.37B, reflecting operational efficiency. Net income dropped to -$2.28B, with an EPS of -$7.97. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan